Pereira named CEO of Visterra; Biovest comes out of Ch. 11; Missing protein may explain fear;

 @FierceBiotech: ICYMI: Merck's positive Alzheimer's study spotlights BACE race. Article | Follow @FierceBiotech

 @JohnCFierce: In pharma, incremental innovation lives on. Story | Follow @JohnCFierce

 @RyanMFierce: A $30.6M financing for Ayasdi, BigData analytics and discovery for life sciences, energy and other industries. Release | Follow @RyanMFierce

> The former CEO of Amag, Brian Pereira, has taken the helm at Visterra, which is focused on infectious diseases. "I envision Visterra as a company with the potential to deliver multiple products from its novel therapeutic platform, and I look forward to working with the strong team that is in place, so that together we will accelerate opportunities to develop and commercialize innovative medicines," Pereira said in a statement. Release

> Tampa-based Biovest has emerged from Chapter 11 with new management. Carlos Santos is the new CEO. Story

> ThermoGenesis and TotipotentRx Corporation have struck a definitive merger agreement. Release

> Probiodrug AG provided an update on PQ912, in clinical development for the treatment of Alzheimer's disease. Release

Medical Device News

 @FierceMedDev: Boston Scientific, Sorin team up on heart valve. Article | Follow @FierceMedDev

 @MarkHFierce: The FDA approved the first Dx test designed to help diagnose ADHD in children and teens. EEG tech is a core element. Press release | Follow @MarkHFierce

 @DamianFierce: No Synthes, no growth for JNJ's medical devices and diagnostics business. Report | Follow @DamianFierce

> Myriad ups patient assistance as it sues cheaper rivals. Story

> NEA invests $4.3M in Cartiva's joint replacement work. Item

Pharma News

 @FiercePharma: China's corruption watchdogs eye 4 more drugmakers as GSK manager confesses to bribery on TV. More | Follow @FiercePharma

 @CarlyHFierce: NICE says no to Pfizer's Bosulif. Been pretty skeptical about new cancer drugs. Release | Follow @CarlyHFierce

> First Manhattan sues Vivus for 'illegally' delaying shareholder vote. News

> J&J drug sales leap 12%, with Zytiga, Stelara leading growth. Article

Biotech Research News

 @EmilyMFierce: Obesity gene found to regulate hunger hormone. More | Follow @EmilyMFierce

> Researchers unveil largest database of cancer-related genetic variations. News

> Senate committee approves funding increase for NIH in FY 2014. Article

> Sorrento Therapeutics, Israeli university team up to fight hep C. Item

Pharma Manufacturing News

 @EricPFierce: BTG said its Biocompatibles unit had received an FDA warning letter for its plant in Oxford, CT. Article | Follow @EricPFierce

> FDA lays out when plant inspection delays will lead to penalties. Report

> Roche to put $105M into training center. News

> Sanofi starts production on complex dengue vaccine. Article

And Finally… Neuroscientists say that a missing brain protein may explain a pathological sense of fear in mice. More